skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

Yamazaki, K. ; Nagase, M. ; Tamagawa, H. ; Ueda, S. ; Tamura, T. ; Murata, K. ; Eguchi Nakajima, T. ; Baba, E. ; Tsuda, M. ; Moriwaki, T. ; Esaki, T. ; Tsuji, Y. ; Muro, K. ; Taira, K. ; Denda, T. ; Funai, S. ; Shinozaki, K. ; Yamashita, H. ; Sugimoto, N. ; Okuno, T. ; Nishina, T. ; Umeki, M. ; Kurimoto, T. ; Takayama, T. ; Tsuji, A. ; Yoshida, M. ; Hosokawa, A. ; Shibata, Y. ; Suyama, K. ; Okabe, M. ; Suzuki, K. ; Seki, N. ; Kawakami, K. ; Sato, M. ; Fujikawa, K. ; Hirashima, T. ; Shimura, T. ; Taku, K. ; Otsuji, T. ; Tamura, F. ; Shinozaki, E. ; Nakashima, K. ; Hara, H. ; Tsushima, T. ; Ando, M. ; Morita, S. ; Boku, N. ; Hyodo, I.

Annals of oncology, 2016-08, Vol.27 (8), p.1539-1546 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Nomograms predicting survival of patients with advanced or recurrent biliary tract cancer receiving a first-line chemotherapy
Nomograms predicting survival of patients with advanced or recurrent biliary tract cancer receiving a first-line chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nomograms predicting survival of patients with advanced or recurrent biliary tract cancer receiving a first-line chemotherapy

Takahara, N. ; Nakai, Y. ; Saito, K.O. ; Sato, M. ; Ooyama, H. ; Kanai, S. ; Suzuki, T. ; Sato, T. ; Hakuta, R. ; Ishigaki, K. ; Takeda, T. ; Mizuno, S. ; Kogure, H. ; Tada, M. ; Koike, K.

Annals of oncology, 2018-10, Vol.29, p.viii262-viii262 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Development of the immuno-wall device for rapid detection of ALK and ROS1 fusions in lung cancer
Development of the immuno-wall device for rapid detection of ALK and ROS1 fusions in lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of the immuno-wall device for rapid detection of ALK and ROS1 fusions in lung cancer

Yogo, N. ; Hase, T. ; Kasama, T. ; Hatta, T. ; OZAWA, N. ; Sato, M. ; Kaji, N. ; Tokeshi, M. ; Baba, Y. ; Hasegawa, Y.

Annals of oncology, 2018-11, Vol.29, p.ix120-ix120 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
P-091Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials
P-091Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

P-091Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials

Maeda, H ; Sato, M ; Kobayashi, M ; Takiguchi, N ; Yoshikawa, T ; Yoshino, S ; Yoshida, K ; Tsuburaya, A ; Sakamoto, J ; Morita, S

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii27-ii27 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
5
407P A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
407P A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
Material Type:
Artigo 		Adicionar ao Meu Espaço

407P A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan

Yamazaki, N. ; Kiyohara, Y. ; Sato, M. ; Endo, S. ; Song, B. ; Tanaka, Y. ; Kambe, A. ; Sato, Y. ; Uhara, H.

Annals of oncology, 2022-11, Vol.33, p.S1601-S1602 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma
Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma

Saijo, Y. ; Sato, G. ; Usui, K. ; Sato, M. ; Sagawa, M. ; Kondo, T. ; Minami, Y. ; Nukiwa, T.

Annals of oncology, 2001-08, Vol.12 (8), p.1121-1125 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
7
Development of the immuno-wall device for rapid, low-cost detection of EGFR mutations in tumor samples from patients with lung cancer
Development of the immuno-wall device for rapid, low-cost detection of EGFR mutations in tumor samples from patients with lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of the immuno-wall device for rapid, low-cost detection of EGFR mutations in tumor samples from patients with lung cancer

Yogo, N. ; Hase, T. ; Kasama, T. ; Ozawa, N. ; Sato, M. ; Kaji, N. ; Tokeshi, M. ; Baba, Y. ; Hasegawa, Y.

Annals of oncology, 2017-11, Vol.28, p.x118-x118 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Efficacy and feasibility of paclitaxel and carboplatin-based concurrent chemoradiotherapy for patients with advanced cervical cancer with renal dysfunction
Efficacy and feasibility of paclitaxel and carboplatin-based concurrent chemoradiotherapy for patients with advanced cervical cancer with renal dysfunction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and feasibility of paclitaxel and carboplatin-based concurrent chemoradiotherapy for patients with advanced cervical cancer with renal dysfunction

Kamiya, N. ; Imai, Y. ; Asai-Sato, M. ; Ota, Y. ; Suzuki, Y. ; Ruiz-Yokota, N. ; Matsunaga, T. ; Miyagi, E.

Annals of oncology, 2017-11, Vol.28, p.x92-x92 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
P-091 Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials
P-091 Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

P-091 Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials

Maeda, H. ; Sato, M. ; Kobayashi, M. ; Takiguchi, N. ; Yoshikawa, T. ; Yoshino, S. ; Yoshida, K. ; Tsuburaya, A. ; Sakamoto, J. ; Morita, S.

Annals of oncology, 2016-06, Vol.27, p.ii27-ii27 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Prospective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)
Prospective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)

Kato, K. ; Komiyama, S. ; Takeshima, N. ; Takano, H. ; Inoue, A. ; Hongo, A. ; Asai-Sato, M. ; Arakawa, A. ; Kubushiro, K. ; Kamiura, S. ; Sugiyama, T.

Annals of oncology, 2017-09, Vol.28, p.v340-v340 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.